Phase II trial of temozolomide in children with recurrent high-grade glioma

By Ruggiero A.   Cefalo G.   Garré M.L.   Massimino M.   Colosimo C.   Attinà G.   Lazzareschi I.   Maurizi P.   Ridola V.   Mazzarella G.   Caldarelli M.   Rocco C.   Madon E.   Abate M.E.   Clerico A.   Sandri A.   Riccardi R.  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

By Su Ying-Wen   Chang Ming-Chih   Chiang Ming-Fu   Hsieh Ruey-Kuen  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma

By van Putten Erik HP   Dirven Clemens MF   van den Bent Martin J   Lamfers Martine LM  

Future Oncology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1691-1710

Future Medicine

Access to resources Recommend Favorite

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option

By Flieger Maya   Ganswindt Ute   Schwarz Silke   Kreth Friedrich-Wilhelm   Tonn Jörg-Christian   Fougère Christian   Ertl Lorenz   Linn Jennifer   Herrlinger Ulrich   Belka Claus   Niyazi Maximilian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 337-345

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children

By Broniscer Alberto   Chintagumpala Murali   Fouladi Maryam   Krasin Matthew   Kocak Mehmet   Bowers Daniel   Iacono Lisa   Merchant Thomas   Stewart Clinton   Houghton Peter   Kun Larry   Ledet Davonna   Gajjar Amar  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 313-319

Springer Publishing Company

Access to resources Recommend Favorite